D. E. Shaw & Co., Inc. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$838,812
-42.9%
42,215
-50.8%
0.00%
-50.0%
Q1 2023$1,468,812
-58.8%
85,745
-52.9%
0.00%
-50.0%
Q4 2022$3,564,910
-50.2%
182,162
-59.4%
0.00%
-55.6%
Q3 2022$7,156,000
+176.2%
448,342
+138.1%
0.01%
+200.0%
Q2 2022$2,591,000
-14.7%
188,301
-1.7%
0.00%0.0%
Q1 2022$3,037,000
-8.2%
191,512
+26.4%
0.00%0.0%
Q4 2021$3,307,000
-40.3%
151,494
-18.3%
0.00%
-40.0%
Q3 2021$5,542,000
-37.4%
185,434
-7.3%
0.01%
-37.5%
Q2 2021$8,859,000
-34.8%
200,018
-34.7%
0.01%
-38.5%
Q1 2021$13,589,000
-22.2%
306,250
-3.9%
0.01%
-18.8%
Q4 2020$17,474,000
+247.6%
318,638
+44.9%
0.02%
+220.0%
Q3 2020$5,027,000
+6.2%
219,879
-2.8%
0.01%
-16.7%
Q2 2020$4,734,000
+63.6%
226,202
+9.1%
0.01%
+20.0%
Q1 2020$2,893,000
+590.5%
207,403
+1025.5%
0.01%
Q4 2019$419,000
+153.9%
18,427
+65.0%
0.00%
Q4 2018$165,000
-73.3%
11,166
-55.4%
0.00%
-100.0%
Q3 2018$617,000
-45.6%
25,056
-56.6%
0.00%0.0%
Q2 2018$1,134,000
-56.6%
57,750
-58.5%
0.00%
-75.0%
Q1 2018$2,610,000139,2000.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders